Inactief instrument

Andere talen Chanticleer Holdings Inc Nasdaq

Aandelen

US15930P4046

slotkoers Nasdaq Andere beurzen
- ^USD	-

11/03	Handelaren anticiperen op inflatierapport terwijl Amerikaanse aandelen lager openen op Wall Street	MT
11/03	Top premarket stijgers	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference	03/05
Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy at the AACR 2024 Annual Meeting	20/03
Traders Anticipate Inflation Report as US Equities Open Lower on Wall Street	11/03
Top Premarket Gainers	11/03
Sonnet BioTherapeutics Holdings, Inc. Announces First Phase 1b/2a Clinical Trial of SON-080	11/03
Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers	01/03
Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update	15/02
Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	14/02
North American Morning Briefing : Stock Futures -2-	09/02
Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy	22/12
North American Morning Briefing : S&P 500 Futures Dip with Fresh Record in Sight	20/12
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update	15/12
Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	14/12
North American Morning Briefing : Traders Await -2-	13/12
Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering	26-10-23
Sector Update: Health Care Stocks Retreating Late Afternoon	25-10-23
Top Midday Decliners	25-10-23
Top Premarket Decliners	25-10-23
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society Annual Meeting	18-10-23
Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology	21-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Chanticleer Holdings Inc Nasdaq

Aandelen

US15930P4046

Andere talen

Filters